These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 17455355)

  • 1. Correlations between molecular mobility and chemical stability during storage of amorphous pharmaceuticals.
    Yoshioka S; Aso Y
    J Pharm Sci; 2007 May; 96(5):960-81. PubMed ID: 17455355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of water on the chemical stability of amorphous pharmaceuticals: I. Small molecules.
    Ohtake S; Shalaev E
    J Pharm Sci; 2013 Apr; 102(4):1139-54. PubMed ID: 23371547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local mobility in amorphous pharmaceuticals--characterization and implications on stability.
    Bhattacharya S; Suryanarayanan R
    J Pharm Sci; 2009 Sep; 98(9):2935-53. PubMed ID: 19499564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of annealing on the stability of amorphous solids: chemical stability of freeze-dried moxalactam.
    Abdul-Fattah AM; Dellerman KM; Bogner RH; Pikal MJ
    J Pharm Sci; 2007 May; 96(5):1237-50. PubMed ID: 17455341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mechanistic investigation of an amorphous pharmaceutical and its solid dispersions, part II: molecular mobility and activation thermodynamic parameters.
    Shmeis RA; Wang Z; Krill SL
    Pharm Res; 2004 Nov; 21(11):2031-9. PubMed ID: 15587925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent trends in stabilising peptides and proteins in pharmaceutical formulation - considerations in the choice of excipients.
    Jorgensen L; Hostrup S; Moeller EH; Grohganz H
    Expert Opin Drug Deliv; 2009 Nov; 6(11):1219-30. PubMed ID: 19678792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glass Transition Dynamics and Physical Stability of Amorphous Griseofulvin in Binary Mixtures with Low-
    Tu W; Knapik-Kowalczuk J; Chmiel K; Paluch M
    Mol Pharm; 2019 Aug; 16(8):3626-3635. PubMed ID: 31287704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical stability of amorphous materials: specific and general media effects in the role of water in the degradation of freeze-dried zoniporide.
    Luthra SA; Shalaev EY; Medek A; Hong J; Pikal MJ
    J Pharm Sci; 2012 Sep; 101(9):3110-23. PubMed ID: 22461087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative assessment of the significance of molecular mobility as a determinant for the stability of lyophilized insulin formulations.
    Yoshioka S; Aso Y
    Pharm Res; 2005 Aug; 22(8):1358-64. PubMed ID: 16078146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temperature- and glass transition temperature-dependence of bimolecular reaction rates in lyophilized formulations described by the Adam-Gibbs-Vogel equation.
    Yoshioka S; Aso Y; Kojima S
    J Pharm Sci; 2004 Apr; 93(4):1062-9. PubMed ID: 14999742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A calorimetric investigation of thermodynamic and molecular mobility contributions to the physical stability of two pharmaceutical glasses.
    Zhou D; Grant DJ; Zhang GG; Law D; Schmitt EA
    J Pharm Sci; 2007 Jan; 96(1):71-83. PubMed ID: 17031846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negligible contribution of molecular mobility to the degradation rate of insulin lyophilized with poly(vinylpyrrolidone).
    Yoshioka S; Aso Y; Miyazaki T
    J Pharm Sci; 2006 Apr; 95(4):939-43. PubMed ID: 16493588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical stability of amorphous pharmaceuticals: Importance of configurational thermodynamic quantities and molecular mobility.
    Zhou D; Zhang GG; Law D; Grant DJ; Schmitt EA
    J Pharm Sci; 2002 Aug; 91(8):1863-72. PubMed ID: 12115813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitigating unwanted amorphisation: A screening method for the selection of suitable excipients.
    Amharar Y; Curtin V; Gallagher KH; O'Siochru E; O'Connell P; Healy AM
    Eur J Pharm Sci; 2016 Jan; 81():181-8. PubMed ID: 26493586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance.
    Alie J; Menegotto J; Cardon P; Duplaa H; Caron A; Lacabanne C; Bauer M
    J Pharm Sci; 2004 Jan; 93(1):218-33. PubMed ID: 14648651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of the onset of crystallization of amorphous sucrose below the calorimetric glass transition temperature from correlations with mobility.
    Bhugra C; Rambhatla S; Bakri A; Duddu SP; Miller DP; Pikal MJ; Lechuga-Ballesteros D
    J Pharm Sci; 2007 May; 96(5):1258-69. PubMed ID: 17455303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of molecular mobility on the physical stability of amorphous pharmaceuticals in the supercooled and glassy States.
    Kothari K; Ragoonanan V; Suryanarayanan R
    Mol Pharm; 2014 Sep; 11(9):3048-55. PubMed ID: 25105216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel approach for analyzing glass-transition temperature vs. composition patterns: application to pharmaceutical compound+polymer systems.
    Kalogeras IM
    Eur J Pharm Sci; 2011 Apr; 42(5):470-83. PubMed ID: 21324354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A molecular dynamics simulation of reactant mobility in an amorphous formulation of a peptide in poly(vinylpyrrolidone).
    Xiang TX; Anderson BD
    J Pharm Sci; 2004 Apr; 93(4):855-76. PubMed ID: 14999724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early drug development predictions of glass-forming ability and physical stability of drugs.
    Mahlin D; Bergström CA
    Eur J Pharm Sci; 2013 May; 49(2):323-32. PubMed ID: 23557841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.